Hypolipidemic Effects of Alkaloids from Rhizoma Coptidis in Diet-Induced Hyperlipidemic Hamsters

Planta Medica

Volumn 82, Issue 8, 2016, Pages 690-697

  He, Kai ^a,b   Kou, Shuming ^a   Zou, Zongyao ^a   Hu, Yinran ^a   Feng, Min ^a,c   Han, Bing ^a   Li, Xuegang ^a   Ye, Xiaoli ^a  

^a SOUTHWEST UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c CHONGQING TECHNOLOGY AND BUSINESS UNIVERSITY   (China)

Author keywords

alkaloids; antihyperlipidemic; hyperlipidemic hamsters; mechanism; Ranunculaceae; Rhizoma Coptidis

Indexed keywords

ALKALOID DERIVATIVE; ANTILIPEMIC AGENT; BERBERINE; BILE ACID; COPTIS RHIZOME EXTRACT; COPTISINE; EPIBERBERINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; JATRORRHIZINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PALMATINE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ALKALOID; CHOLESTEROL; HERBACEOUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE ACID BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; COPTIS; DRUG EFFECT; DRUG SCREENING; EXPERIMENTAL HAMSTER; HYPERLIPIDEMIA; MALE; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHEMISTRY; HYPERLIPIDEMIAS; ISOLATION AND PURIFICATION; LIPID DIET; MESOCRICETUS; RANUNCULACEAE;

ALKALOIDS; ANIMALS; CHOLESTEROL; DIET, HIGH-FAT; DRUGS, CHINESE HERBAL; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; MALE; MESOCRICETUS; RANUNCULACEAE; TRIGLYCERIDES;

EID: 84957710519     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0035-1568261     Document Type: Article

References (42)

1. Yan W. Efficiency comparison of aerobic exercise combination of stomach muscle training in abdominal obesity individual. Chinese J Gerontol: 2015; 2 477 479
2. Genest J., Mcpherson R., Frohlich J., Anderson T., Campbell N., Carpentier A., Couture P., Dufour R., Fodor G., Francis G. A., Grover S., Gupta M., Hegele R. A., Lau D. C., Leiter L., Lewis G. F., Lonn E., Mancini G. B., Ng D., Pearson G. J., Sniderman A., Stone J. A., Ur E. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Can J Cardiol: 2009; 25 567 579
3. Liu H. H., Li J. J. Aging and dyslipidemia: a review of potential mechanisms. Ageing Res Rev: 2015; 19 43 52
4. Li Z. Y., Yang R. F., Xu G. B., Xia T. Serum lipid concentrations and prevalence of dyslipidemia in a large professional population in Beijing. Clin Chem: 2005; 51 144 150
5. Manickam P., Rathod A., Panaich S., Hari P., Veeranna V., Badheka A., Jacob S., Afonso L. Comparative prognostic utility of conventional and novel lipid parameters for cardiovascular disease risk prediction: do novel lipid parameters offer an advantage? J Clin Lipidol: 2011; 5 82 90
6. Ioannides-Demos L. L., Piccenna L., Mcneil J. J. Pharmacotherapies for obesity: past, current, and future therapies. J Obes: 2011; 2011 179674
7. Group U. DS. U.K. Prospective Diabetes Study 27. Plasma lipids and lipoproteins at diagnosis of NIDDM by age and sex. Diabetes Care: 1997; 20 1683 1687
8. Ikeda H., Taketomi S., Sugiyama Y., Shimura Y., Sohda T., Meguro K., Fujita T. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arzneimittelforsch: 1990; 40 156 162
9. Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., Wang Y., Wang Z., Si S., Pan H., Wang S., Wu J., Wang Y., Li Z., Liu J., Jiang J. D. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med: 2004; 10 1344 1351
10. Hu Y., Ehli E. A., Kittelsrud J., Ronan P. J., Munger K., Downey T., Bohlen K., Callahan L., Munson V., Jahnke M., Marshall L., Nelson K., Huizenga P., Hansen R., Soundy T., Davies G. E. Lipid-lowering effect of berberine in human subjects and rats. Phytomedicine: 2012; 19 861 867
11. Lee Y. S., Kim W. S., Kim K. H., Yoon M. J., Cho H. J., Shen Y., Ye J. M., Lee C. H., Oh W. K., Kim C. T., Behrens C. H., Gosby A., Kraegen E. W., James D. E., Kim J. B. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes: 2006; 55 2256 2264
12. Brusq J. M., Ancellin N., Grondin P., Guillard R., Martin S., Saintillan Y., Issandou M. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine. J Lipid Res: 2006; 47 1281 1288
13. Hui D., Yan Z., Li Z., Fuer L. The effects of berberine on blood lipids: a systemic review and meta-analysis of randomized controlled trials. Planta Med: 2013; 79 437 446
14. Kahlon T., Chow F., Knuckles B., Chiu M. Cholesterol-lowering effects in hamsters of b-glucan-enriched barley fraction, dehulled whole barley, rice bran, and oat bran and their combinations. Cereal Chem: 1993; 70 435 440
15. Hokanson J. E., Austin M. A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a metaanalysis of population-based prospective studies. J Cardiovasc Risk: 1996; 3 213 219
16. Assmann G., Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Am J Cardiol: 1992; 70 733 737
17. Brehm B. J., Seeley R. J., Daniels S. R., DAlessio D. A. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab: 2003; 88 1617 1623
18. Bartness T. J., Wade G. N. Photoperiodic control of seasonal body weight cycles in hamsters. Neurosci Biobehav Rev: 1985; 9 599 612
19. Haerer W., Delbaere K., Bartlett H., Lord S., Rowland J. Relationships between HMG-CoA reductase inhibitors (statin) use and strength, balance and falls in older people. Intern Med J: 2012; 42 1329 1334
20. Notarnicola M., Messa C., Refolo M. G., Tutino V., Miccolis A., Caruso M. G. Synergic effect of eicosapentaenoic acid and lovastatin on gene expression of HMGCoA reductase and LDL receptor in cultured HepG2 cells. Lipids Health Dis: 2010; 9 135 143
21. Han H., Xin P., Zhao L., Xu J., Xia Y., Yang X. Excess iodine and high-fat diet combination modulates lipid profile, thyroid hormone, and hepatic LDLr expression values in mice. Biol Trace Elem Res: 2012; 147 233 239
22. Chen Q., Wang E., Ma L., Zhai P. Dietary resveratrol increases the expression of hepatic 7 α -hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL/6 J mice. Lipids Health Dis: 2012; 11 56 63
23. Chiang J. YL. Bile acids: regulation of synthesis. J Lipid Res: 2009; 50 1955 1966
24. Lan T., Rao A., Haywood J., Kock N. D., Dawson P. A. Mouse organic solute transporter alpha deficiency alters FGF15 expression and bile acid metabolism. J Hepatol: 2012; 57 359 365
25. Walters J. R., Tasleem A. M., Omer O. S., Brydon W. G., Dew T., le Roux C. W. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol: 2009; 7 1189 1194
26. Out C., Patankar J. V., Doktorova M., Boesjes M., Bos T., de Boer S., Havinga R., Wolters H., Boverhof R., van Dijk T. H., Smoczek A., Bleich A., Sachdev V., Kratky D., Kuipers F., Verkade H. J., Groen A. K. Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4. J Hepatol: 2015; 63 697 704
27. Divakaruni A. S., Brand M. D. The regulation and physiology of mitochondrial proton leak. Physiology (Bethesda): 2011; 26 192 205
28. Mailloux R. J., Harper M. E. Uncoupling proteins and the control of mitochondrial reactive oxygen species production. Free Radic Biol Med: 2011; 51 1106 1115
29. Oktavianthi S., Trimarsanto H., Febinia C. A., Suastika K., Saraswati M. R., Dwipayana P., Arindrarto W., Sudoyol H., Malik S. G. Uncoupling protein 2 gene polymorphisms are associated with obesity. Cardiovasc Diabetol: 2012; 11 41 51
30. Oh K., Kim M., Lee J., Kim M., Nam Y., Ham J. Liver PPARalpha and UCP2 are involved in the regulation of obesity and lipid metabolism by swim training in genetically obese db/db mice. Biochem Biophys Res Commun: 2006; 345 1232 1239
31. Harper M. E., Dent R., Monemdjou S., Bézaire V., Van W. L., Wells G., Kavaslar G. N., Tesson F., McPherson R. Decreased mitochondrial proton leak and reduced expression of uncoupling protein 3 in skeletal muscle of obese diet-resistant women. Diabetes: 2002; 51 2459 2466
32. Faggioni R., Shigenaga J., Moser A., Feingold K. R., Grunfeld C. Induction of UCP2 gene expression by LPS: a potential mechanism for increased thermogenesis during infection. Biochem Biophys Res Commun: 1998; 244 75 78
33. Jung H. A., Min B. S., Yokozawa T., Lee J. H., Kim Y. S., Choi J. S. Anti-Alzheimer and antioxidant activities of Coptidis Rhizoma alkaloids. Biol Pharm Bull: 2009; 32 1433 1438
34. Wang L., Ye X., Li X., Chen Z., Chen X., Gao Y., Zhao Z., Huang W., Chen X., Yi J. [Metabolism, transformation and distribution of Coptis chinensis total alkaloids in rat]. China J Chinese Materia Med (Zhongguo Zhong Yao Za Zhi): 2010; 35 2017 2020
35. Yu S., Yu Y., Liu L., Wang X., Lu S., Liang Y., Liu X., Xie L., Wang G. Increased plasma exposures of five protoberberine alkaloids from Coptidis Rhizoma in streptozotocin-induced diabetic rats: is P-GP Involved? Planta Med: 2010; 76 876 881
36. Kim H. S., Kim M. J., Kim E. J., Yang Y., Lee M. S., Lim J. S. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem Pharmacol: 2012; 83 385 394
37. Jiang Q., Liu P., Wu X., Liu W., Shen X., Lan T., Xu S., Peng J., Xie X., Huang H. Berberine attenuates lipopolysaccharide-induced extracelluar matrix accumulation and inflammation in rat mesangial cells: involvement of NF- κ B signaling pathway. Mol Cell Endocrinol: 2011; 331 34 40
38. Sangeetha M., Priya C., Vasanthi H. R. Anti-diabetic property of Tinospora cordifolia and its active compound is mediated through the expression of Glut-4 in L6 myotubes. Phytomedicine: 2013; 20 246 248
39. Chen H. Y., Ye X. L., Cui X. L., He K., Jin Y. N., Chen Z. Cytotoxicity and antihyperglycemic effect of minor constituents from Rhizoma Coptis in HepG2 cells. Fitoterapia: 2012; 83 67 73
40. Monte M. J., El-Mir M. Y., Sainz G. R., Bravo P., Marin J. G. Bile acid secretion during synchronized rat liver regeneration. Biochim Biophys Acta: 1997; 1362 56 66
41. Laura C. B., Noemí R., Catherine F., Rosa R., Francisco B. V., Joan C. Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5/G8. J Lipid Res: 2008; 49 904 911
42. Barber R. D., Harmer D. W., Coleman R. A., Clark B. J. GAPDH as a housekeeping gene: analysis of GAPDH mRNA expression in a panel of 72 human tissues. Physiol Genomics: 2005; 21 389 395